{"id":"https://openalex.org/W2145354262","doi":"https://doi.org/10.1530/eje-07-0815","title":"Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes","display_name":"Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes","alternate_titles":[],"publication_year":2008,"publication_date":"2008-04-22","ids":{"openalex":"https://openalex.org/W2145354262","doi":"https://doi.org/10.1530/eje-07-0815","mag":"2145354262","pmid":"https://pubmed.ncbi.nlm.nih.gov/18426821"},"language":"en","primary_location":{"id":"doi:10.1530/eje-07-0815","doi":"https://doi.org/10.1530/eje-07-0815","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje-07-0815","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145354262"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://cris.maastrichtuniversity.nl/en/publications/12322891-3f63-4cb1-93c6-4bd845a42a20","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112364410","display_name":"S\u00f8ren S\u00f8gaard Lund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1339947260","display_name":"Steno Diabetes Centers","ror":"https://ror.org/03w7awk87","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I1339947260","https://openalex.org/I2802567020","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"S\u00f8ren S Lund","raw_affiliation_strings":["Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark. sqrl@steno.dk","Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark. sqrl@steno.dk","institution_ids":["https://openalex.org/I1339947260"]},{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070884818","display_name":"Lise Tarnow","orcid":"https://orcid.org/0000-0002-8735-966X","observed_orcids":["https://orcid.org/0000-0002-8735-966X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lise Tarnow","raw_affiliation_strings":["Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016620300","display_name":"Coen D.A. Stehouwer","orcid":"https://orcid.org/0000-0001-8752-3223","observed_orcids":["https://orcid.org/0000-0001-8752-3223"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Coen D A Stehouwer","raw_affiliation_strings":["Division of General Internal Medicine, Department of Internal Medicine, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of General Internal Medicine, Department of Internal Medicine, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031265369","display_name":"Casper G. Schalkwijk","orcid":"https://orcid.org/0000-0003-0190-2690","observed_orcids":["https://orcid.org/0000-0003-0190-2690"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Casper G Schalkwijk","raw_affiliation_strings":["Department of Clinical Chemistry, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands","Division of General Internal Medicine, Department of Internal Medicine, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"Division of General Internal Medicine, Department of Internal Medicine, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045835727","display_name":"Tom Teerlink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tom Teerlink","raw_affiliation_strings":["Department of Clinical Chemistry, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025976955","display_name":"J\u00f8rgen Gram","orcid":"https://orcid.org/0000-0002-0203-1965","observed_orcids":["https://orcid.org/0000-0002-0203-1965"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]},{"id":"https://openalex.org/I4210134581","display_name":"Hospital South West Jutland","ror":"https://ror.org/03pzgk858","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210134581"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J\u00f8rgen Gram","raw_affiliation_strings":["Department of Thrombosis Research, Ribe County Hospital, University of Southern Denmark and Department of Clinical Biochemistry, 6700 Esbjerg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thrombosis Research, Ribe County Hospital, University of Southern Denmark and Department of Clinical Biochemistry, 6700 Esbjerg, Denmark","institution_ids":["https://openalex.org/I177969490","https://openalex.org/I4210134581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053869539","display_name":"Kaj Winther","orcid":"https://orcid.org/0000-0001-7778-0939","observed_orcids":["https://orcid.org/0000-0001-7778-0939"]},"institutions":[{"id":"https://openalex.org/I2801150652","display_name":"Frederiksberg Hospital","ror":"https://ror.org/00d264c35","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801150652","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kaj Winther","raw_affiliation_strings":["Department of Clinical Biochemistry, Frederiksberg Hospital, 2000 Frederiksberg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biochemistry, Frederiksberg Hospital, 2000 Frederiksberg, Denmark","institution_ids":["https://openalex.org/I2801150652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012329193","display_name":"M. Frandsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Merete Frandsen","raw_affiliation_strings":["Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072740074","display_name":"U. Smidt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ulla M Smidt","raw_affiliation_strings":["Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066665434","display_name":"Oluf Borbye Pedersen","orcid":"https://orcid.org/0000-0002-3321-3972","observed_orcids":["https://orcid.org/0000-0002-3321-3972"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Oluf Pedersen","raw_affiliation_strings":["Faculty of Health Sciences, University of Aarhus, 8000 Aarhus, Denmark","Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Health Sciences, University of Aarhus, 8000 Aarhus, Denmark","institution_ids":["https://openalex.org/I204337017"]},{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111749912","display_name":"Hans\u2010Henrik Parving","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans-Henrik Parving","raw_affiliation_strings":["Department of Medical Endocrinology, University of Copenhagen, Rigshospitalet, 2000 Copenhagen, Denmark","Faculty of Health Sciences, University of Aarhus, 8000 Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Endocrinology, University of Copenhagen, Rigshospitalet, 2000 Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802709434"]},{"raw_affiliation_string":"Faculty of Health Sciences, University of Aarhus, 8000 Aarhus, Denmark","institution_ids":["https://openalex.org/I204337017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069291545","display_name":"Allan Arthur Vaag","orcid":"https://orcid.org/0000-0002-3690-2191","observed_orcids":["https://orcid.org/0000-0002-3690-2191"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Allan A Vaag","raw_affiliation_strings":["Department of Endocrinology, University of Lund, S-20502 Malm\u00f6, Sweden","Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, University of Lund, S-20502 Malm\u00f6, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5112364410"],"corresponding_institution_ids":["https://openalex.org/I1339947260"],"apc_list":{"value":3798,"currency":"EUR","value_usd":4292},"apc_paid":null,"fwci":5.937,"has_fulltext":false,"cited_by_count":107,"citation_normalized_percentile":{"value":0.96943931,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"158","issue":"5","first_page":"631","last_page":"641"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/repaglinide","display_name":"repaglinide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9700000286102295},{"id":"https://openalex.org/keywords/non-obese-patients","display_name":"non-obese patients","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cardiovascular-risk-markers","display_name":"cardiovascular risk markers","score":0.7310000061988831},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.9459999799728394},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":1.0},{"id":"https://openalex.org/keywords/insulin-secretagogues","display_name":"insulin secretagogues","score":0.9039999842643738},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9639999866485596},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.890999972820282},{"id":"https://openalex.org/keywords/soluble-cell-adhesion-molecules","display_name":"soluble adhesion molecules","score":0.6610000133514404},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.8500000238418579},{"id":"https://openalex.org/keywords/advanced-glycation-end-products","display_name":"advanced glycation end products","score":0.781000018119812},{"id":"https://openalex.org/keywords/asymmetric-dimethylarginine","display_name":"asymmetric dimethylarginine","score":0.8600000143051147},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7839999794960022},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8769039511680603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8091328144073486},{"id":"https://openalex.org/C2781281211","wikidata":"https://www.wikidata.org/wiki/Q2195995","display_name":"Repaglinide","level":4,"score":0.7998829483985901},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.797632098197937},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6583514213562012},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6231822371482849},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5593826770782471},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.5572538375854492},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5411386489868164},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5238164067268372},{"id":"https://openalex.org/C2779394231","wikidata":"https://www.wikidata.org/wiki/Q412310","display_name":"Von Willebrand factor","level":3,"score":0.5164821147918701},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.49700644612312317},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4898824095726013},{"id":"https://openalex.org/C2780675426","wikidata":"https://www.wikidata.org/wiki/Q410485","display_name":"Plasminogen activator inhibitor-1","level":3,"score":0.43386268615722656},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.4178847372531891},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.06725993752479553}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014657","descriptor_name":"Vasculitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014657","descriptor_name":"Vasculitis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014657","descriptor_name":"Vasculitis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":10,"locations":[{"id":"doi:10.1530/eje-07-0815","doi":"https://doi.org/10.1530/eje-07-0815","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje-07-0815","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},{"id":"pmid:18426821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18426821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of endocrinology","raw_type":"Comparative Study"},{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/12322891-3f63-4cb1-93c6-4bd845a42a20","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/12322891-3f63-4cb1-93c6-4bd845a42a20","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lund, S S, Tarnow, L, Stehouwer, C D A, Schalkwijk, C G, Teerlink, T, Gram, J, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H H & Vaag, A A 2008, 'Impact of metformin versus repaglinide on non-glycemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, pp. 631-41. https://doi.org/10.1530/EJE-07-0815","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/a4da076f-053f-410a-ad2b-b613b41f572a","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/a4da076f-053f-410a-ad2b-b613b41f572a","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lund, S S, Tarnow, L, Stehouwer, C D A, Schalkwijk, C G, Teerlink, T, Gram, J, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H H & Vaag, A A 2008, 'Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, no. 5, pp. 631-641. https://doi.org/10.1530/EJE-07-0815","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/0a33d0ac-e483-4247-baf1-3cc674fc56d7","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/0a33d0ac-e483-4247-baf1-3cc674fc56d7","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lund, S S, Tarnow, L, Stehouwer, C D A, Schalkwijk, C G, Teerlink, T, Gram, J, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H H & Vaag, A A 2008, 'Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, no. 5, pp. 631-641. https://doi.org/10.1530/EJE-07-0815","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/68bc0e00-ee1d-11dd-bf70-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/68bc0e00-ee1d-11dd-bf70-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lund, S S, Tarnow, L, Stehouwer, C D A, Schalkwijk, C G, Teerlink, T, Gram, J, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H-H & Vaag, A A 2008, 'Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, no. 5, pp. 631-41. https://doi.org/10.1530/EJE-07-0815","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/1d0cd090-639c-11dd-b1a1-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/1d0cd090-639c-11dd-b1a1-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lund, S S, Tarnow, L, Stehouwer, C DA, Schalwwijk, C G, Teerlink, T, Gram, J B, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H-H & Vaag, A A 2008, 'Impact of metformin versus repaglinide on non-glucaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, pp. 631-641. https://doi.org/10.1530/EJE-07-0815","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lup.lub.lu.se:1eeb8122-3209-41f1-bded-5b17b0eb1111","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/1204204","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 0804-4643","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/12322891-3f63-4cb1-93c6-4bd845a42a20","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/12322891-3f63-4cb1-93c6-4bd845a42a20","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Endocrinology, 158, 631 - 41. BioScientifica Ltd.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/0a33d0ac-e483-4247-baf1-3cc674fc56d7","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/0a33d0ac-e483-4247-baf1-3cc674fc56d7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Endocrinology, 158(5), 631 - 641. BioScientifica Ltd.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/12322891-3f63-4cb1-93c6-4bd845a42a20","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/12322891-3f63-4cb1-93c6-4bd845a42a20","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lund, S S, Tarnow, L, Stehouwer, C D A, Schalkwijk, C G, Teerlink, T, Gram, J, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H H & Vaag, A A 2008, 'Impact of metformin versus repaglinide on non-glycemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, pp. 631-41. https://doi.org/10.1530/EJE-07-0815","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W1651383390","https://openalex.org/W1928726551","https://openalex.org/W1964957922","https://openalex.org/W1967504606","https://openalex.org/W1969296390","https://openalex.org/W1974012256","https://openalex.org/W1986245421","https://openalex.org/W1987894901","https://openalex.org/W1989089571","https://openalex.org/W1989742048","https://openalex.org/W1990383789","https://openalex.org/W1995897557","https://openalex.org/W1997443963","https://openalex.org/W1998393556","https://openalex.org/W2005971589","https://openalex.org/W2011656517","https://openalex.org/W2013633841","https://openalex.org/W2014759828","https://openalex.org/W2015899437","https://openalex.org/W2027974633","https://openalex.org/W2029335415","https://openalex.org/W2032485049","https://openalex.org/W2040745954","https://openalex.org/W2042518766","https://openalex.org/W2043851240","https://openalex.org/W2046159055","https://openalex.org/W2050191746","https://openalex.org/W2052240447","https://openalex.org/W2052410736","https://openalex.org/W2056507272","https://openalex.org/W2057651652","https://openalex.org/W2059665864","https://openalex.org/W2064409668","https://openalex.org/W2069150029","https://openalex.org/W2079812128","https://openalex.org/W2082799310","https://openalex.org/W2083441169","https://openalex.org/W2088318611","https://openalex.org/W2089593291","https://openalex.org/W2092362047","https://openalex.org/W2099114113","https://openalex.org/W2113746520","https://openalex.org/W2115256479","https://openalex.org/W2117465409","https://openalex.org/W2117756660","https://openalex.org/W2118067027","https://openalex.org/W2118154631","https://openalex.org/W2118476557","https://openalex.org/W2132308332","https://openalex.org/W2133891706","https://openalex.org/W2142473378","https://openalex.org/W2147891699","https://openalex.org/W2148752419","https://openalex.org/W2149602039","https://openalex.org/W2151259510","https://openalex.org/W2157677292","https://openalex.org/W2159665702","https://openalex.org/W2160389935","https://openalex.org/W2161201002","https://openalex.org/W2161310510","https://openalex.org/W2165391345","https://openalex.org/W2169417490","https://openalex.org/W2171285048","https://openalex.org/W2184880683","https://openalex.org/W2188846692","https://openalex.org/W2315801165","https://openalex.org/W2331274940","https://openalex.org/W4233324980"],"related_works":["https://openalex.org/W4252103460","https://openalex.org/W1969296390","https://openalex.org/W2062018857","https://openalex.org/W1964957922","https://openalex.org/W2148752419","https://openalex.org/W2079162205","https://openalex.org/W1969743766","https://openalex.org/W2056246205","https://openalex.org/W4414435068","https://openalex.org/W2333290374"],"abstract_inverted_index":{"OBJECTIVE:":[0],"In":[1,26,161,217],"patients":[2,90,99],"with":[3,123,235],"type":[4],"2":[5,104],"diabetes":[6],"mellitus":[7],"(T2DM),":[8],"biomarkers":[9,52,228],"reflecting":[10,229],"inflammation":[11,230],"and":[12,23,30,88,150,165,185,197,231],"endothelial":[13,232],"dysfunction":[14,233],"have":[15,33],"been":[16],"linked":[17],"to":[18,102],"cardiovascular":[19],"disease":[20,209],"(CVD":[21],"biomarkers)":[22],"metabolic":[24],"regulation.":[25],"T2DM":[27,55,78,219],"patients,":[28,220],"metformin":[29,44,113,157,171,221],"insulin":[31,47],"secretagogues":[32],"demonstrated":[34],"equal":[35],"anti-hyperglycaemic":[36],"potency.":[37],"Here,":[38],"we":[39],"report":[40],"the":[41,89,213],"effect":[42],"of":[43,131,175],"versus":[45,158,172],"an":[46],"secretagogue,":[48],"repaglinide,":[49],"on":[50,95],"CVD":[51],"in":[53,225],"non-obese":[54,70,218],"patients.":[56,79],"DESIGN":[57],"AND":[58],"METHODS:":[59],"Single-centre,":[60],"double-masked,":[61],"double-dummy,":[62],"crossover":[63],"study":[64],"during":[65,120,156,170],"2x4":[66],"months":[67,122],"involving":[68],"96":[69],"(body":[71],"mass":[72],"index<":[73],"or":[74,116],"=27":[75],"kg/m(2))":[76],"insulin-na\u00efve":[77],"At":[80],"enrolment,":[81],"previous":[82],"oral":[83],"hypoglycaemic":[84],"agents":[85],"were":[86,100,153,168,201],"stopped":[87],"entered":[91],"a":[92,124],"1-month":[93,125],"run-in":[94],"diet-only":[96],"treatment.":[97],"Hereafter,":[98],"randomized":[101],"either":[103],"mg":[105],"repaglinide":[106,159,236],"thrice":[107],"daily":[108,115],"followed":[109],"by":[110],"1":[111],"g":[112],"twice":[114],"vice":[117],"versa":[118],"each":[119],"4":[121],"washout":[126],"between":[127,203,241],"interventions.":[128],"RESULTS:":[129],"Levels":[130,174],"tumour":[132],"necrosis":[133],"factor-alpha,":[134],"plasminogen":[135,140],"activator":[136,141],"inhibitor-1":[137],"antigen,":[138,142],"tissue-type":[139],"von":[143],"Willebrand":[144],"factor,":[145],"soluble":[146,151,178],"intercellular":[147],"adhesion":[148,181],"molecule-1":[149],"E-selectin":[152],"significantly":[154],"lower":[155],"treatments.":[160,204,242],"contrast,":[162],"Amadori":[163],"albumin":[164],"heart":[166],"rate":[167],"higher":[169],"repaglinide.":[173],"interleukin-6,":[176],"fibrinogen,":[177],"vascular":[179],"cell":[180],"molecule-1,":[182],"asymmetric":[183],"dimethylarginine":[184],"advanced":[186],"glycation":[187],"end":[188],"products":[189],"as":[190,192],"well":[191],"glycaemic":[193,239],"levels":[194,240],"(previously":[195],"reported)":[196],"24-h":[198],"blood":[199],"pressure":[200],"similar":[202,238],"Adjustment":[205],"for":[206],"known":[207],"macrovascular":[208],"did":[210],"not":[211],"affect":[212],"between-treatment":[214],"effects.":[215],"CONCLUSIONS:":[216],"was":[222],"more":[223],"effective":[224],"reducing":[226],"selected":[227],"compared":[234],"despite":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145354262","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
